Epirubicin: all 157 studies that test it

Page 2 of 2. Open to participants first (16), then studies with results posted, then the rest; newest registration first within each.

• Pre-operative Chemotherapy in Operable Breast Cancer, Phase III Study Comparing a Short Intensive Pre-operative Chemotherapy With the Same Therapy Initiated Shortly After Surgery(Peri-operatively)(POCOB)EORTC 10902)Status unknownNCT00544505Not applicable
• Preoperative Epirubicin Paclitaxel Aranesp Study (PREPARE)CompletedNCT00544232Phase 3
• BREAST-10: Three-weekly Versus Weekly First-line Chemotherapy for Metastatic or Locally Advanced Breast CancerCompletedNCT00540800Phase 3
• Neoadjuvant Chemotherapy of Primary Breast Cancer With Epirubicin/Docetaxel and Carboplatin/DocetaxelCompletedNCT00527449Phase 2
• Investigating the Biological Effects of the Addition of Zoledronic Acid to Pre-operative Chemotherapy in Breast CancerCompletedNCT00525759Phase 2
• Doxorubicin or Epirubicin and Cyclophosphamide in Treating Older Women With Invasive Breast CancerStatus unknownNCT00516425Phase 3
• Capecitabine, Epirubicin, and Carboplatin in Treating Patients With Progressive, Unresectable, or Metastatic CancerCompletedNCT00486356Phase 1
• Randomized Phase II Study of Epirubicin vs Caelyx in Pretreated Metastatic Breast CancerTerminatedNCT00431795Phase 2
• Randomized Phase III Trial With Docetaxel Plus Epirubicine Versus Docetaxel Plus Capecitabine for Metastatic Breast CancerCompletedNCT00429871Phase 3
• Epirubicin and Docetaxel Combination (ET) or Epirubicin Followed by Docetaxel (E/T) for Node Negative (N0) High Risk Breast Cancer PatientsCompletedNCT00424606Phase 3
• Docetaxel, Epirubicin, and Cyclophosphamide With or Without Trastuzumab in Treating Women With Locally Advanced Breast Cancer That Can Be Removed By SurgeryStatus unknownNCT00398489Phase 2
• Epirubicin and Cyclophosphamide Followed By Docetaxel and Trastuzumab in Treating Women With HER2-Positive Stage III or Stage IV Breast CancerCompletedNCT00379015Phase 2
• A Study of Gemcitabine, Epirubicin, and Paclitaxel Combination Chemotherapy Given Before Surgery to Patients With Locally Advanced Breast CancerCompletedNCT00378313Phase 2
• Randomized Study Comparing Pre- and Postoperative vs. Conventional Adjuvant Treatment in Receptor-negative PatientsCompletedNCT00309569Phase 3
• Epirubicin in Treating Women Who Are Undergoing Surgery for Stage I, Stage II, or Stage III Breast CancerCompletedNCT00253500Phase 2
• Phase I Trial of Valproic Acid and Epirubicin in Solid Tumor MalignanciesCompletedNCT00246103Phase 1
• High-dose Chemotherapy With Autologous Stem Cell Transplantation in Poor Prognosis Germ-cell Tumors: TAXIF IICompletedNCT00231582Phase 2
• Neoadjuvant Epirubicin, Cisplatin and Capecitabine (ECX) Followed by Definitive Chemoradiation With/Without Surgery for Squamous Cell Carcinoma of the OesophagusCompletedNCT00220129Phase 2
• Pre-operative Epirubicin, Cisplatin, and Capecitabine in Patients With Newly Diagnosed Localised Oesophageal AdenocarcinomaCompletedNCT00220103Phase 2
• A Study of Epirubicin With Estramustine Phosphate and Celecoxib for the Treatment of Prostate CancerStatus unknownNCT00218205Phase 2
• Adjuvant Chemoradiation Therapy for Gastric or Gastroesophageal Junction AdenocarcinomaCompletedNCT00215514Early Phase 1
• A Multicenter Trial Comparing Induction C/T Followed by CCRT v.s. CCRT Alone in Stage IV Nasopharyngeal CarcinomaCompletedNCT00201396Phase 3
• Phase II Study of Cisplatin Plus Epirubicin Salvage Chemo in Refractory Germ Cell TumorsTerminatedNCT00198172Phase 2
• Epirubicin and Docetaxel in the Treatment of Patients With Metastatic Breast CancerTerminatedNCT00193024Phase 2
• Topoisomerase II Alpha Gene Amplification and Protein Overexpression Predicting Efficacy of EpirubicinTerminatedNCT00162812Phase 2
• Gemcitabine/Cisplatin Versus Gemcitabine/Epirubicin for Non-Small Cell Lung Cancer (NSCLC)CompletedNCT00154739Phase 2
• Cytoxan, Epirubicin and Capecitabine in Women With Breast CancerCompletedNCT00146588Not applicable
• Study of Epirubicin (Pharmorubicin®), Carboplatin (Paraplatin®) and Capecitabine (Xeloda®) (ECC) in the Treatment of Unresectable Locally Advanced or Metastatic Gastric/Gastroesophageal Junction Cancer With Pharmacogenetic CorrelatesTerminatedNCT00130936Phase 1/2
• A Feasibility Study to Evaluate Adjuvant Chemoradiotherapy for Gastric CancerCompletedNCT00123318Phase 3
• Study of Alimta and Epirubicin Administered in Patients With Locally Advanced or Metastatic Breast CancerCompletedNCT00097383Phase 1/2
• Epirubicin and Docetaxel in Treating Patients With Metastatic Prostate CancerTerminatedNCT00096304Phase 1
• Docetaxel and Epirubicin as First-Line Therapy in Treating Patients With Locally Advanced or Metastatic Adenocarcinoma of the StomachStatus unknownNCT00075465Phase 2
• Neoadjuvant or Adjuvant Epirubicin, Cyclophosphamide, and Paclitaxel in Treating Women With Stage I, Stage II, or Stage III Breast CancerCompletedNCT00072319Phase 2
• Neoadjuvant Epirubicin, Cyclophosphamide, and Paclitaxel With or Without Gemcitabine in Treating Women Who Are Undergoing Surgery for Early Breast CancerStatus unknownNCT00070278Phase 3
• Epirubicin, Docetaxel, and Pegfilgrastim in Treating Women With Locally Advanced or Inflammatory Breast CancerCompletedNCT00066443Phase 1/2
• Epirubicin and Rituximab in Treating Patients With Relapsed or Refractory B-Cell Non-Hodgkin's Lymphoma or Chronic Lymphocytic LeukemiaCompletedNCT00062296Phase 2
• Epirubicin and Thalidomide in Treating Patients With Liver CancerCompletedNCT00058487Phase 2
• Epirubicin and Celecoxib in Treating Patients With Hepatocellular CarcinomaCompletedNCT00057980Phase 1/2
• Combination Chemotherapy in Treating Women With Stage I Breast CancerCompletedNCT00055679Phase 3
• Combination Chemotherapy in Treating Women With Breast Cancer Who Have Undergone SurgeryStatus unknownNCT00039546Phase 3
• Combination Chemotherapy in Treating Women With Resected Breast CancerStatus unknownNCT00033683Phase 2
• Combination Chemotherapy in Treating Patients With Metastatic Cancer of an Unknown Site of OriginStatus unknownNCT00022178Phase 3
• Epirubicin, Carboplatin, and Capecitabine in Treating Patients With Unresectable Locally Advanced, Metastatic, or Recurrent Solid TumorCompletedNCT00021047Phase 1/2
• Epirubicin Plus Irinotecan in Treating Patients With Advanced CancerCompletedNCT00020748Phase 1
• Gemcitabine and Epirubicin in Treating Patients With Malignant MesotheliomaCompletedNCT00017186Phase 2
• Epirubicin and Tamoxifen With or Without Docetaxel in Treating Postmenopausal Women With Breast CancerStatus unknownNCT00010140Phase 3
• Combination Chemotherapy Before Surgery in Treating Women With Breast CancerCompletedNCT00008034Phase 1
• Combination Chemotherapy in Treating Women With Stage II or Stage III Breast CancerStatus unknownNCT00005581Phase 3
• Paclitaxel and Carboplatin With or Without Epirubicin in Treating Patients With Stage IIB, Stage III, or Stage IV Invasive Ovarian Epithelial, Fallopian Tube, or Peritoneal CancerCompletedNCT00004934Phase 3
• Combination Chemotherapy in Treating Patients With Advanced Stomach CancerCompletedNCT00004873Phase 2
• Comparison of Three Combination Chemotherapy Regimens in Treating Women With Stage I or Stage II Breast CancerCompletedNCT00004237Phase 2
• Combination Chemotherapy in Treating Patients With Extensive Stage Small Cell Lung CancerCompletedNCT00003606Phase 3
• Combination Chemotherapy With or Without Epirubicin in Treating Women With Stage I or Stage II Breast CancerCompletedNCT00003577Phase 3
• Combination Chemotherapy Following Surgery in Treating Women With Early Stage Breast CancerCompletedNCT00003012Phase 3
• Epirubicin and Cyclophosphamide Compared With Epirubicin and Paclitaxel in Treating Women With Metastatic Breast CancerCompletedNCT00002953Phase 3
• Docetaxel and Epirubicin With and Without G-CSF in Treating Women With Metastatic Breast CancerCompletedNCT00002866Phase 1
• Hormone Therapy and Chemotherapy in Treating Perimenopausal or Postmenopausal Women With Node-Positive Breast CancerCompletedNCT00002529Phase 3

← Epirubicin overview